Systemic lupus erythematosus pregnancy

Giving birth to a healthy baby is every mother's dream, but for some people, this dream is difficult to achieve. Systemic lupus erythematosus is a type of immune system disease. It is not recommended for women to become pregnant after developing this disease, because systemic lupus erythematosus needs timely treatment, otherwise it will have serious effects on the body. It is recommended that every patient with systemic lupus erythematosus must choose to become pregnant after being cured so that they can have a healthy baby.

Systemic lupus erythematosus has certain genetic factors, especially mother-to-child transmission. As long as the expectant mother is in good health, the next generation will be relatively healthier. If you are diagnosed with systemic lupus erythematosus while preparing for pregnancy, it is recommended that you recuperate your body before having a baby.

The onset of systemic lupus erythematosus (SLE) is the result of the interaction between genetic and environmental factors. Since the disease spreads through the blood itself, the various autoantibodies present in the patient's serum can reach various organs throughout the body through blood circulation. Its lesions can affect multiple organs and tissues, posing a great threat to the patient's health. Pregnancy with systemic lupus erythematosus affects the health of both pregnant women and fetuses.

Patients with systemic lupus erythematosus should not become pregnant: Systemic lupus erythematosus (SLE for short) is a serious autoimmune disease that is common in young women. Patients with systemic lupus erythematosus should not become pregnant.

Women with systemic lupus erythematosus should avoid pregnancy: Systemic lupus erythematosus (SLE) is an autoimmune disease whose cause is not yet fully understood. SLE is the most common disease of connective tissue. 80% of the patients are women, most of whom develop the disease between the ages of 20 and 40.

What are the characteristics of fever in lupus erythematosus: Systemic lupus erythematosus is an autoimmune disease that often affects many systems and organs. The disease is more common in female school-age children and is often accompanied by fever and other symptoms.

Systemic lupus erythematosus is more common in young and middle-aged women. The incidence rate in women of childbearing age is 9 to 3 times higher than that in men of the same age. However, the incidence rate in prepubertal and postmenopausal women is low, only slightly higher than that in men. The estrogen levels in young and middle-aged women of childbearing age are much higher than those of the general population. A large number of studies have confirmed that estrogen plays an important role in the pathogenesis of systemic lupus erythematosus. It can inhibit cellular immunity and increase the formation of autoantibodies. In clinical practice, it is also found that some patients develop the disease after menarche or after delivery. Oral contraceptives containing estrogen can also induce the disease. About 1/3 of systemic lupus erythematosus patients have worsening of the disease during pregnancy, or the disease turns from the original remission period to the active period after delivery.

Systemic lupus erythematosus is a disease that has a great impact on women's physical health. Because it is more common in young women, many women lose the opportunity to become mothers. Although technology is advancing and more drugs have been invented, the treatment of systemic lupus erythematosus has always been a difficult problem in the medical community. Before this, I hope that pregnant patients with systemic lupus erythematosus can look at this issue rationally.